Cite
HARVARD Citation
Song, Y. et al. (2021). Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma. Expert review of hematology. 14 (9), pp. 867-875. [Online].